Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Minerva Neurosciences, Inc (NERV)

« Back to company index

NERV Chatter Timeline

Stock Ticker for NERV

Most Active Tweeters for NERV

UserTweets
@thefinreviewer 8
@BlogYomi 4
@UlmHi 4
@bulletin_en 2
@jeromeverony 2

Recent Tweets for NERV

thefinreviewer @thefinreviewer
Crinetics Pharmaceuticals Inc. $NERV Contrasting side by side https://t.co/BJWXUAGjbb
April 18th 2019, 5:04pm
bulletin_en @bulletin_en
Reviewing Pfenex Inc. $NERV's results https://t.co/aksHVlthSy
April 18th 2019, 1:04am
jeromeverony @jeromeverony
RT @SeekingAlpha: $NERV - Minerva Neurosciences: A Lacklustre Proposition All Around https://t.co/cVub67zEff
April 17th 2019, 3:04pm
jeromeverony @jeromeverony
Minerva Neurosciences: A Lacklustre Proposition All Around $NERV https://t.co/MvHCprVaFT
April 17th 2019, 2:04pm
SeekingAlpha @SeekingAlpha
$NERV - Minerva Neurosciences: A Lacklustre Proposition All Around https://t.co/cVub67zEff
April 17th 2019, 2:04pm
BlogYomi @BlogYomi
Minerva Neurosciences $NERV Share Price Rose While New Leaf Venture Partners Has Raised by $1.76 Million Its Holdin… https://t.co/yA1zilWGRR
April 17th 2019, 12:04pm
UlmHi @UlmHi
New Leaf Venture Partners Continues to Hold Position in Minerva Neurosciences $NERV; Pfizer $PFE Shareholder First… https://t.co/pRwQZ2tjXX
April 17th 2019, 8:04am
Stock_News_Now @Stock_News_Now
$NERV: New SEC Filing for NERV: Form DEFA14A (No. 0001193125-19-108372): https://t.co/FYw6uvhoJv
April 17th 2019, 8:04am
Biotech_Beast @Biotech_Beast
$NERV's roluperidone is set to produce results from a phase 3 trial in negative symptoms of schizophrenia in mid-20… https://t.co/3BCnYZ9IQP
April 17th 2019, 8:04am
BioPharmInsight @BioPharmInsight
What are $NERV’s MIN-101 Phase III schizophrenia trial prospects? @ShaunSim asks experts if the trial design and MO… https://t.co/XKUQ0sFfEl
April 17th 2019, 7:04am
StockTexts @StockTexts
$NERV Minerva Neurosciences, Inc SEC Filing: Form DEFA14A https://t.co/dKVtEuCXk1
April 17th 2019, 7:04am
xiscan1 @xiscan1
#ValueInvesting $NERV Analysis via: @SeekingAlpha $NERV - A Look At The Competitors To Minerva's Roluperidone https://t.co/RLLzIivmkP
April 17th 2019, 6:04am
SeekingAlpha @SeekingAlpha
$NERV - A Look At The Competitors To Minerva's Roluperidone https://t.co/VkeIcjmwMk
April 17th 2019, 6:04am
macondailynews @macondailynews
Minerva Neurosciences $NERV Downgraded to “Hold” at ValuEngine https://t.co/RTfyFao3QW
April 17th 2019, 2:04am
UlmHi @UlmHi
22nd Century Group Inc. $NERV Comparing side by side https://t.co/M6KkBqD7lh
April 16th 2019, 11:04pm
thefinreviewer @thefinreviewer
As Minerva Neurosciences $NERV Market Value Rose, New Leaf Venture Partners Has Raised by $1.76 Million Its Stake;… https://t.co/xXenC6acui
April 16th 2019, 5:04am
WeekHerald @WeekHerald
Minerva Neurosciences $NERV Downgraded by ValuEngine https://t.co/csY9ZsDTaa
April 16th 2019, 2:04am
ThisLincolnian @ThisLincolnian
ValuEngine Downgrades Minerva Neurosciences $NERV to Hold https://t.co/vjNaHOfH6W
April 16th 2019, 2:04am
thefinreviewer @thefinreviewer
Biohaven Pharmaceutical Holding Company Ltd. $NERV Comparison side by side https://t.co/iVtH258FQN
April 16th 2019, 2:04am
thefinreviewer @thefinreviewer
Reviewing Gamida Cell Ltd. $NERV's results https://t.co/u3No1upRVC
April 16th 2019, 1:04am
UlmHi @UlmHi
Contrasting of Corbus Pharmaceuticals Holdings Inc. $NERV https://t.co/kcR6G8ETV9
April 15th 2019, 10:04pm
bibeypost_stock @bibeypost_stock
Today Minerva Neurosciences, Inc. $NERV Stock Rises https://t.co/PW4Es6cIgu
April 15th 2019, 3:04pm
dispatchtribune @dispatchtribune
ValuEngine Downgrades Minerva Neurosciences $NERV to Hold https://t.co/UGwcjIXR39
April 15th 2019, 1:04am
EnterpriseLeade @EnterpriseLeade
ValuEngine Downgrades Minerva Neurosciences $NERV to Hold https://t.co/ppiyKDDhou
April 15th 2019, 1:04am
registrarjourn @registrarjourn
ValuEngine Downgrades Minerva Neurosciences $NERV to Hold https://t.co/FEVvJK7P7g
April 15th 2019, 1:04am
dakotafinancial @dakotafinancial
Minerva Neurosciences $NERV Downgraded by ValuEngine https://t.co/4MiXd2OaP5
April 14th 2019, 10:04am
thefinreviewer @thefinreviewer
Odonate Therapeutics Inc. $NERV https://t.co/tmzG69PmxQ
April 13th 2019, 11:04pm
mmahotstuff1 @mmahotstuff1
Could Minerva Neurosciences, Inc. $NERV Gain Strenght? The Stock Reaches 1 Year Low https://t.co/fEAjN982lf
April 13th 2019, 2:04pm
whatsonthorold2 @whatsonthorold2
Minerva Neurosciences, Inc. $NERV Stock Price Declines Today https://t.co/TZ374G3stX
April 13th 2019, 2:04pm
VM1409 @VM1409
RT @StockNewsWires: $NERV: Minerva withdraws filing for $200M mixed shelf: https://t.co/a1lMfZdzUG
April 11th 2019, 6:04pm
StockNewsWires @StockNewsWires
$NERV: Minerva withdraws filing for $200M mixed shelf: https://t.co/a1lMfZdzUG
April 11th 2019, 4:04pm
Nonfiction8879 @Nonfiction8879
Minerva withdraws filing for $200M mixed shelf $NERV https://t.co/cSIJwtsQb4
April 11th 2019, 4:04pm
MarketCurrents @MarketCurrents
$NERV - Minerva withdraws filing for $200M mixed shelf https://t.co/CufZd3znjG
April 11th 2019, 4:04pm
Jon12508683 @Jon12508683
if $nerv drug works for negative symptoms of schizophrenia, stock will be much higher. but that’s a big if.
April 11th 2019, 11:04am
Briefingcom @Briefingcom
$NERV: Minerva Neurosciences presents pre-clinical data suggesting a mechanistic role of roluperidone in addressing… https://t.co/NGA15ScRnZ
April 11th 2019, 10:04am
thefinreviewer @thefinreviewer
Jaguar Health Inc. $NERV Contrasting side by side https://t.co/JInfPk1KXa
April 11th 2019, 3:04am
biopadawan @biopadawan
@path1finder $nerv u positive about coming data in April?
April 10th 2019, 1:04pm
UlmHi @UlmHi
Vital Therapies Inc. $NERV https://t.co/JG41Poxccb
April 10th 2019, 12:04pm
thefinreviewer @thefinreviewer
California State Teachers Retirement System Holds Holding in Schlumberger LTD $SLB; Minerva Neurosciences $NERV Sha… https://t.co/8eCD0F3UOi
April 10th 2019, 5:04am
reurope_stock @reurope_stock
Minerva Neurosciences Inc $NERV Has Increase in Shorts https://t.co/hGQyqJ8RHz
April 9th 2019, 3:04pm
path1finder @path1finder
added additional positions in $NERV and $RVNC today
April 9th 2019, 2:04pm
BlogYomi @BlogYomi
New Leaf Venture Partners Raised Minerva Neurosciences $NERV Position; As Service Intl $SCI Stock Declined, Td Asse… https://t.co/N674VGCkyA
April 9th 2019, 6:04am
BlogYomi @BlogYomi
Highland Capital Management LP Has Lowered Its Stake in Minerva Neurosciences $NERV by $1.69 Million as Market Valu… https://t.co/DRRrWmbCSn
April 8th 2019, 12:04pm
BlogYomi @BlogYomi
Comparing of Zai Lab Limited $NERV https://t.co/eoo6PWgqV0
April 8th 2019, 11:04am
bulletin_en @bulletin_en
Sphera Funds Management LTD Has Cut Its Position in Minerva Neurosciences $NERV by $362,238 as Stock Price Rose; As… https://t.co/N2PC1rJNJI
April 7th 2019, 9:04am
ConsumerFeed @ConsumerFeed
Zacks: Brokerages Expect Minerva Neurosciences Inc $NERV to Post -$0.35 Earnings Per Share https://t.co/Q6bEGXmMLY
April 6th 2019, 3:04pm
thefinreviewer @thefinreviewer
Comparing of Aquestive Therapeutics Inc. $NERV https://t.co/P2BXkhReuz
April 6th 2019, 3:04am
BlogYomi @BlogYomi
Reviewing Gossamer Bio Inc. $NERV's results https://t.co/Z4R7nLtsli
April 5th 2019, 7:04pm
dakotafinancial @dakotafinancial
-$0.35 EPS Expected for Minerva Neurosciences Inc $NERV This Quarter https://t.co/SIode1yZsc
April 4th 2019, 11:04pm
bulletin_en @bulletin_en
Reviewing iBio Inc. $NERV's results https://t.co/UDwy0nRA97
April 4th 2019, 8:04pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.